Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05557643 · ClinicalTrials.gov registry record · Phase 1
PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related Burnout
A Phase 1 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT05557643 is a Phase 1 study that has completed, run by University of Utah. The registered enrollment target is 24 participants.
The verdict
NCT05557643, a Phase 1 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
This project is an open-label randomized study looking at an 8-week Mindfulness-Based Stress Reduction (MBSR) curriculum vs. an 8-week MBSR curriculum + a group psilocybin-assisted psychotherapy intervention for frontline healthcare providers struggling with symptoms of depression and burnout associated with the SARS-CoV-2 pandemic. Following consenting and enrollment a total of 24 participants will be randomized to receive either an 8-week MBSR curriculum or the same 8-week MBSR curriculum + a group psilocybin-assisted psychotherapy intervention. The group psilocybin-assisted psychotherapy intervention will involve 3 group preparatory sessions (2 hours each), a single 8 hour group psilocybin administration session with a 1:1 therapist to participant ratio (25mg psilocybin dose), and 3 group integration sessions (2 hours each).
Interventions
- DRUG Psilocybin
- BEHAVIORAL Mindfulness-Based Stress Reduction (MBSR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-01-02 |
| Est. Completion | 2024-09-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05557643
The ClinicalTrials.gov registry entry for NCT05557643 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Psilocybin is the first listed.
NCT05557643 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05557643 about?
NCT05557643 is a clinical study titled "PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related Burnout". This project is an open-label randomized study looking at an 8-week Mindfulness-Based Stress Reduction (MBSR) curriculum vs. an 8-week MBSR curriculum + a group psilocybin-assisted psychotherapy intervention for frontline healthcare providers struggling with symptoms of depression and burnout associ...
What is the current status of trial NCT05557643?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2023-01-02. Estimated completion is 2024-09-20.
What interventions are being tested in trial NCT05557643?
The interventions under investigation include: Psilocybin (DRUG), Mindfulness-Based Stress Reduction (MBSR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05557643?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.